FAIR Biogen is a beauty-tech disruptor leveraging proprietary biotech, AI, and advanced platforms like SymbioTech™ to deliver sustainable, scalable luxury solutions. With innovations like ISMYZ-5™ and TapTech™, we combine personalization, data-driven insights, and global market potential to redefine the future of beauty. FAIR stands at the intersection of technology and eco-conscious luxury, driving transformative growth in the $674B industry.
Current Status
FAIR Biogen is in the early growth stage, with a fully developed and tested product portfolio powered by proprietary innovations like ISMYZ-5™ Complex, TapTech™, and SymbioTech™. Our MVP (Minimum Viable Product) has been validated through beta testing with exceptional results, and we are actively preparing for a go-to-market launch. Early partnerships and customer feedback loops have refined our strategy, positioning us for scalable commercialization and entry into key luxury retail, digital channels and licensing.
Key Insight:
Even capturing 0.1% of this massive market (i.e., $674M) would establish FAIR Biogen as a profitable, high-growth player in the beauty space. Our multi-channel strategy—spanning luxury retailers, celebrity collaborations, and advanced formulations—positions us to scale beyond this initial milestone and claim a larger share of the $674B addressable market over time.
Problem or Opportunity
Beauty Problems:
Fragrance: Scent fades quickly, requiring frequent reapplication and 70% is lost to air.
Skincare: No one single product adapts to the skin’s shifting needs—leaving dryness, irritation, or inadequate protection unaddressed.
Makeup: Formulations don’t adapt to the skin resulting in uneven coverage, color mismatch, and short-lived wear.
Solution (product or service)
FAIR Biogen Beauty Solutions:
Fragrance: Powered by AI driven cellular reprogramming, scent lasts up to 36 hours, nano-tech sensors enable reapplication directly from the skin, reducing evaporation to less than 5%.
Skincare: Biologically personalized all-in-one nano-tech solution, addressing aging, wrinkling, dryness, and irritation; delivering naturally radiant and revitalized skin.
Makeup: Adaptive nano-tech makeup solutions seamlessly sync with the skin to deliver a flawless finish whilst enhancing its natural radiance.
Competitors
FAIR Biogen operates in a blue ocean market, with no direct competitors offering our unique combination of biotech-driven personalization, AI-powered innovation, and sustainable luxury solutions. While traditional luxury beauty brands dominate the market, they rely on legacy formulations and lack the proprietary technology that sets FAIR apart. Alternatives for customers include generic perfumes and cosmetics that fail to deliver the adaptive performance and eco-conscious benefits of our solutions. FAIR’s first-mover advantage positions us to capture market share rapidly and establish a new standard in the $674B global beauty industry.
Advantages or differentiators
FAIR Biogen’s indisputable advantage lies in its proprietary technologies, including ISMYZ-5™ Complex for personalized, long-lasting performance, TapTech™ for automated scent optimization, and SymbioTech™, a fusion of biotechnology and sustainability. These innovations are protected and backed by cutting-edge R&D investments, creating a high barrier to entry for competitors.
Our unique value proposition is amplified by:
- AI-driven customization: Adapts to individual skin chemistry in real time.
- Sustainable luxury: Eco-friendly formulations without compromising performance or prestige.
- Scalable IP licensing: Monetizing our tech through white-label partnerships, ensuring recurring revenue streams.
These differentiators position FAIR Biogen as a category-defining leader, setting standards competitors cannot replicate without significant time, cost, and expertise.
Finance
Brand Building:
- Launch in wholly owned boutiques and select luxury retailers to position FAIR as a go-to eco-conscious, high-performance brand
- Integrate offline promotions (pop-ups, in-store events) with high-impact digital campaigns to boost brand visibility by 50% within six months
- Target luxury-seeking and tech-savvy audiences who value sustainability and cutting-edge formulations
Manufacturing:
- We handle R&D, formulation, and manufacturing on behalf of partner brands—mitigating their R&D and capital investment
- Partners can reduce product development cycles by 100%, tapping into trends before competitors
- Our ISO-certified processes and strict quality controls ensure reliable performance and regulatory compliance
- Brands pay for access to ISMYZ-5™’s proprietary nano-molecular processes, creating a high-margin revenue stream
- Recurring orders for raw materials and formulations reinforce long-term relationships and predictable cash flow
- Each new partner adds to our revenue base, allowing us to rapidly expand without significant extra overhead
Money will be spent on
1) Brand Building & Marketing
2) Boutiques & Retail
3) R&D
4) White Label Manufacturing & Licensing
5) Operations & Team Growth
Offer for investor
We are prepared to offer a strategic equity stake in FAIR Biogen, commensurate with the $35 million investment and aligned with our valuation and growth projections. While the exact percentage will be finalized through collaborative negotiations, our focus is on securing value-aligned investors who bring strategic expertise, market access, and long-term vision to accelerate our trajectory. At the meeting, we will evaluate terms based on a data-driven valuation model, ensuring both parties are positioned for mutual growth and success.
